Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05793086 · ClinicalTrials.gov registry record

Evaluation of a Novel Class of Objective Myofascial Pain Assessments

A clinical trial of Myofascial Pain and Trigger Point Pain, Myofascial, sponsored by Beth Israel Deaconess Medical Center.

Active
Registry status
90
Enrollment target
2
Study locations

NCT05793086: Active study of Myofascial Pain and Trigger Point Pain, Myofascial, sponsored by Beth Israel Deaconess Medical Center.

NCT05793086 is a study of Myofascial Pain and Trigger Point Pain, Myofascial that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 90 participants, above the 63-participant average among 8 other Myofascial Pain trials with a reported enrollment target (43% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05793086, a study of Myofascial Pain and Trigger Point Pain, Myofascial, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.

ACTIVE NOT RECRUITING
Registry status
90 participants
Enrollment target
2
Study locations

Study Summary

This is an observational study that is intended to determine the capacity of three technologies to serve as diagnostic biomarkers for myofascial pain syndrome. Investigators will seek patients with myofasical pain syndrome as well as healthy subjects for this study. Electrical impedance myography (EIM), myofiber threshold tracking (TT) excitability testing, and ultrasound with shear wave elastography (SWE) measurements will be obtained from the trapezius muscle (the muscle that extends over the back of the neck and shoulders). These measurements will be repeated within 2-5 days to assess repeatability of these methods.

Primary Outcome

The primary outcome will be 100 kHz phase angle in EIM

Conditions Studied

Myofascial Pain Trigger Point Pain, Myofascial

Interventions

  • DIAGNOSTIC_TEST Ultrasound
  • DIAGNOSTIC_TEST Electrical impedance myography
  • DIAGNOSTIC_TEST Excitability testing

Study Locations (2)

Massachusetts

  • Massachusetts General Hospital - Boston
  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2023-01-27
Est. Completion 2026-12-01
Beth Israel Deaconess Medical Center

488 total trials

What the registry record for NCT05793086 still lists

NCT05793086 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, above the 63-participant average among 8 other Myofascial Pain trials with a reported enrollment target (43% higher).

The record links to 2 conditions, with Myofascial Pain appearing as the primary indexed condition, and to 3 interventions - of which Ultrasound is the first listed.

NCT05793086 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05793086 about?

NCT05793086 is a clinical study titled "Evaluation of a Novel Class of Objective Myofascial Pain Assessments". This is an observational study that is intended to determine the capacity of three technologies to serve as diagnostic biomarkers for myofascial pain syndrome. Investigators will seek patients with myofasical pain syndrome as well as healthy subjects for this study. Electrical impedance myography (E...

What is the current status of trial NCT05793086?

This trial is currently active not recruiting. The enrollment target is 90 participants. The study started on 2023-01-27. Estimated completion is 2026-12-01.

What conditions does trial NCT05793086 study?

This clinical trial studies the following conditions: Myofascial Pain, Trigger Point Pain, Myofascial.

What interventions are being tested in trial NCT05793086?

The interventions under investigation include: Ultrasound (DIAGNOSTIC_TEST), Electrical impedance myography (DIAGNOSTIC_TEST), Excitability testing (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05793086?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05793086 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myofascial Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05793086's enrollment target sits among peer trials

90 3rd of 8 higher than 6 of 8 other Myofascial Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myofascial Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05793086, the US trial registry maintained by the National Library of Medicine. NCT05793086 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.